RCTS are the only appropriate way to demonstrate the role of vitamin D in health

Journal of Steroid Biochemistry and Molecular Biology

Volumn 177, Issue , 2018, Pages 10-14

  Jorde, Rolf ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Mendelian randomization; Observational trials; Randomized controlled trials; Reverse causality; Vitamin D

Indexed keywords

VITAMIN D; VITAMIN;

CAUSALITY; HEALTH; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; MORTALITY; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN SUPPLEMENTATION; DIETARY SUPPLEMENT; OBSERVATIONAL STUDY;

DIETARY SUPPLEMENTS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMINS;

EID: 85018874430     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2017.05.004     Document Type: Review

References (50)

1. DeLuca, H.F., Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80:6 Suppl (2004), 1689S–1696S.
2. Reid, I.R., What diseases are causally linked to vitamin D deficiency?. Arch. Dis. Child. 101 (2016), 185–189.
3. Garland, F.C., Garland, C.F., Gorham, E.D., Young, J.F., Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 19 (1990), 614–622.
4. Holick, M.F., Vitamin D deficiency. N. Engl. J. Med. 357 (2007), 266–281.
5. Hill, A.B., The environment and disease: association or causation?. Proc. R. Soc. Med. 58 (1965), 295–300.
6. Grant, W.B., How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: an examination using Hill's criteria for causality. Dermatoendocrinology 1 (2009), 17–24.
7. Mohr, S.B., Gorham, E.D., Alcaraz, J.E., Kane, C.I., Macera, C.A., Parsons, J.K., Wingard, D.L., Garland, C.F., Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria. Dermatoendocrinology 4 (2012), 152–157.
8. Jorde, R., Figenschau, Y., Emaus, N., Hutchinson, M., Grimnes, G., Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55 (2010), 792–798.
9. Scragg, R., Sowers, M., Bell, C., Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am. J. Hypertens. 20 (2007), 713–719.
10. Forman, J.P., Giovannucci, E., Holmes, M.D., Bischoff-Ferrari, H.A., Tworoger, S.S., Willett, W.C., Curhan, G.C., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007), 1063–1069.
11. Kristal-Boneh, E., Froom, P., Harari, G., Ribak, J., Association of calcitriol and blood pressure in normotensive men. Hypertension 30 (1997), 1289–1294.
12. Kawashima, H., Receptor for 1,25-dihydroxyvitamin D in a vascular smooth muscle cell line derived from rat aorta. Biochem. Biophys. Res. Commun. 146 (1987), 1–6.
13. Forman, J.P., Williams, J.S., Fisher, N.D., Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 55 (2010), 1283–1288.
14. Beveridge, L.A., Struthers, A.D., Khan, F., Jorde, R., Scragg, R., Macdonald, H.M., Alvarez, J.A., Boxer, R.S., Dalbeni, A., Gepner, A.D., et al. Effect of Vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern. Med. 175 (2015), 745–754.
15. Jorde, R., Figenschau, Y., Hutchinson, M., Emaus, N., Grimnes, G., High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur. J. Clin. Nutr. 64 (2010), 1457–1464.
16. Afzal, S., Brøndum-Jacobsen, P., Bojesen, S.E., Nordestgaard, B.G., Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ, 349, 2014, g6330.
17. Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., Carmeliet, G., Vitamin, D., Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol. Rev. 96 (2016), 365–408.
18. Liu, D., Fernandez, B.O., Hamilton, A., Lang, N.N., Gallagher, J.M., Newby, D.E., Feelisch, M., Weller, R.B., UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J. Invest. 134 (2014), 1839–1846.
19. Fleury, N., Geldenhuys, S., Gorman, S., Sun exposure and its effects on human health: mechanisms through which sun exposure could reduce the risk of developing obesity and cardiometabolic dysfunction. Int. J. Environ. Res. Public Health, 13, 2016, E999.
20. Hiramoto, K., Ultraviolet A irradiation of the eye activates a nitric oxide-dependent hypothalamo-pituitary pro-opiomelanocortin pathway and modulates the functions of Langerhans cells. J. Dermatol. 36 (2009), 335–345.
21. Golden, R.N., Gaynes, B.N., Ekstrom, R.D., Hamer, R.M., Jacobsen, F.M., Suppes, T., Wisner, K.L., Nemeroff, C.B., The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am. J. Psychiatry 162 (2005), 656–662.
22. Minihane, A.M., Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins. Eur. J. Clin. Nutr. 67 (2013), 536–540.
23. Skulas-Ray, A.C., Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. Prostaglandins Other Lipid Mediat. 116–117 (2015), 104–111.
24. Bisgaard, H., Stokholm, J., Chawes, B.L., Vissing, N.H., Bjarnadóttir, E., Schoos, A.M., Wolsk, H.M., Pedersen, T.M., Vinding, R.K., Thorsteinsdóttir, S., et al. Fish oil-Derived fatty acids in pregnancy and wheeze and asthma in offspring. N. Engl. J. Med. 375 (2016), 2530–2539.
25. Jorde, R., Sneve, M., Emaus, N., Figenschau, Y., Grimnes, G., Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur. J. Nutr. 49 (2010), 401–407.
26. Kamycheva, E., Joakimsen, R.M., Jorde, R., Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway. J. Nutr. 133 (2003), 102–106.
27. Didriksen, A., Burild, A., Jakobsen, J., Fuskevåg, O.M., Jorde, R., Vitamin D3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D3. Eur. J. Endocrinol. 172 (2015), 235–241.
28. Vimaleswaran, K.S., Berry, D.J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L.T., Cooper, J.D., Dastani, Z., Li, R., Houston, D.K., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med., 10, 2013, e1001383.
29. Reid, D., Toole, B.J., Knox, S., Talwar, D., Harten, J., O'Reilly, D.S., Blackwell, S., Kinsella, J., McMillan, D.C., Wallace, A.M., The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 93 (2011), 1006–1011.
30. Bhatt, A., Evolution of clinical research: a history before and beyond james lind. Perspect. Clin. Res. 1 (2010), 6–10.
31. Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ, 348, 2014, g2035.
32. Jorde, R., Grimnes, G., Vitamin D and health: the need for more randomized controlled trials. J. Steroid Biochem. Mol. Biol. 148 (2015), 269–274.
33. Bolland, M.J., Grey, A., Gamble, G.D., Reid, I.R., The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2 (2014), 307–320.
34. Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., El-Hajj Fuleihan, G., Josse, R.G., Lips, P., Morales-Torres, J., IOF committee of scientific advisors (CSA) nutrition working group: global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20 (2009), 1807–1820.
35. Durup, D., Jørgensen, H.L., Christensen, J., Tjønneland, A., Olsen, A., Halkjær, J., Lind, B., Heegaard, A.M., Schwarz, P., A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD study. J. Clin. Endocrinol. Metab. 100 (2015), 2339–2346.
36. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., Kiel, D.P., Streeten, E.A., Ohlsson, C., Koller, D.L., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376 (2010), 180–188.
37. Vimaleswaran, K.S., Cavadino, A., Berry, D.J., LifeLines Cohort Study investigators Jorde, R., Dieffenbach, A.K., Lu, C., Alves, A.C., Heerspink, H.J., Tikkanen, E., et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2 (2014), 719–729.
38. Mokry, L.E., Ross, S., Ahmad, O.S., Forgetta, V., Smith, G.D., Goltzman, D., Leong, A., Greenwood, C.M., Thanassoulis, G., Richards, J.B., Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med., 12, 2015, e1001866.
39. Brøndum-Jacobsen, P., Benn, M., Afzal, S., Nordestgaard, B.G., No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int. J. Epidemiol. 44 (2015), 651–661.
40. Afzal, S., Brøndum-Jacobsen, P., Bojesen, S.E., Nordestgaard, B.G.4, Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2 (2014), 298–306.
41. Ye, Z., Sharp, S.J., Burgess, S., Scott, R.A., Imamura, F., InterAct Consortium Langenberg, C., Wareham, N.J., Forouhi, N.G., Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 3 (2015), 35–42.
42. Scragg, R., Stewart, A.W., Waayer, D., Lawes, C.M., Toop, L., Sluyter, J., Murphy, J., Khaw, K.T., Camargo, CA Jr., Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D assessment study: a randomized clinical trial. JAMA Cardiol.(April 5), 2017, 10.1001/jamacardio.2017.0175 Epub ahead of print.
43. Manson, J.E., Bassuk, S.S., Lee, I.M., Cook, N.R., Albert, M.A., Gordon, D., Zaharris, E., Macfadyen, J.G., Danielson, E., Lin, J., et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33 (2012), 159–171.
44. Neale, R.E., Armstrong, B.K., Baxter, C., Duarte Romero, B., Ebeling, P., English, D.R., Kimlin, M.G., McLeod, D.S., O Connell, R.L., van der Pols, J.C., et al. The D-health trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemp. Clin. Trials 48 (2016), 83–90.
45. Pilz, S., Rutters, F., Dekker, J.M., Disease prevention: vitamin D trials. Science, 338, 2012, 883.
46. Priemel, M., von Domarus, C., Klatte, T.O., Kessler, S., Schlie, J., Meier, S., Proksch, N., Pastor, F., Netter, C., Streichert, T., et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 25 (2010), 305–312.
47. Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., Durazo-Arvizu, R.A., Gallagher, J.C., Gallo, R.L., Jones, G., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96 (2011), 53–58.
48. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., Murad, M.H., Weaver, C.M., Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96 (2011), 1911–1930.
49. Bouillon, R., Van Schoor, N.M., Gielen, E., Boonen, S., Mathieu, C., Vanderschueren, D., Lips, P., Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J. Clin. Endocrinol. Metab. 98 (2013), E1283–304.
50. Cashman, K.D., Kiely, M., Kinsella, M., Durazo-Arvizu, R.A., Tian, L., Zhang, Y., Lucey, A., Flynn, A., Gibney, M.J., Vesper, H.W., et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys. Am. J. Clin. Nutr. 97 (2013), 1235–1242.